EGFR and myocardial infarction: While EGFR TKIs are generally well tolerated, cardiotoxicities (including QT interval prolongation, left ventricular ejection fraction (LVEF) reduction, myocardial infarction (MI), atrial fibrillation (AF), and heart failure (HF)) have been reported for some TKIs [15] (Table 1).